These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31197486)

  • 1. Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small cell lung cancer (NSCLC).
    Trinidad López C; De La Fuente Aguado J; Oca Pernas R; Delgado Sánchez-Gracián C; Santos Armentia E; Vaamonde Liste A; Prada González R; Souto Bayarri M
    Eur Radiol Exp; 2019 Jun; 3(1):23. PubMed ID: 31197486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.
    Fraioli F; Anzidei M; Serra G; Liberali S; Fiorelli A; Zaccagna F; Longo F; Anile M; Catalano C
    Br J Radiol; 2013 Sep; 86(1029):20120174. PubMed ID: 23908346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of computed tomography perfusion parameters in non-small-cell-lung-cancer and its relationship to histology, size, stage an treatment response.
    Trinidad López C; Souto Bayarri M; Oca Pernas R; Delgado Sánchez-Gracián C; González Vázquez M; Vaamonde Liste A; Tardáguila De La Fuente G; De La Fuente Aguado J
    Clin Imaging; 2018; 50():5-12. PubMed ID: 29223410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.
    Tacelli N; Santangelo T; Scherpereel A; Duhamel A; Deken V; Klotz E; Cortot A; Lafitte JJ; Wallyn F; Remy J; Remy-Jardin M
    Eur Radiol; 2013 Aug; 23(8):2127-36. PubMed ID: 23553586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
    Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
    BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour response in non-small-cell lung cancer patients treated with chemoradiotherapy - Can spectral CT predict recurrence?
    Fehrenbach U; Feldhaus F; Kahn J; Böning G; Maurer MH; Renz D; Frost N; Streitparth F
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):641-649. PubMed ID: 31282130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.
    Hwang SH; Yoo MR; Park CH; Jeon TJ; Kim SJ; Kim TH
    Eur Radiol; 2013 Jun; 23(6):1573-81. PubMed ID: 23300040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced perfusion area detector CT for non-small cell lung cancer patients: Influence of mathematical models on early prediction capabilities for treatment response and recurrence after chemoradiotherapy.
    Ohno Y; Koyama H; Fujisawa Y; Yoshikawa T; Seki S; Sugihara N; Sugimura K
    Eur J Radiol; 2016 Jan; 85(1):176-186. PubMed ID: 26724663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bronchial and pulmonary blood supply in non-small cell lung cancer subtypes using computed tomography perfusion.
    Nguyen-Kim TD; Frauenfelder T; Strobel K; Veit-Haibach P; Huellner MW
    Invest Radiol; 2015 Mar; 50(3):179-86. PubMed ID: 25500892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic volume perfusion computed tomography parameters versus RECIST for the prediction of outcome in lung cancer patients treated with conventional chemotherapy.
    Sudarski S; Shi J; Schmid-Bindert G; Manegold C; Pilz LR; Zhou C; Schoenberg SO; Henzler T
    J Thorac Oncol; 2015 Jan; 10(1):164-71. PubMed ID: 25247342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
    Ma Q; Min K; Wang T; Chen B; Wen Q; Wang F; Ji T; Gao S
    Ann Nucl Med; 2015 Jul; 29(6):519-27. PubMed ID: 25911312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced perfusion area-detector CT assessed with various mathematical models: Its capability for therapeutic outcome prediction for non-small cell lung cancer patients with chemoradiotherapy as compared with that of FDG-PET/CT.
    Ohno Y; Fujisawa Y; Koyama H; Kishida Y; Seki S; Sugihara N; Yoshikawa T
    Eur J Radiol; 2017 Jan; 86():83-91. PubMed ID: 28027771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-pass perfusion of non-small-cell lung cancer (NSCLC) with 64-detector-row CT: a study of technique repeatability and intra- and interobserver variability.
    Larici AR; Calandriello L; Amato M; Silvestri R; del Ciello A; Molinari F; de Waure C; Vita ML; Carnassale G; Bonomo L
    Radiol Med; 2014 Jan; 119(1):4-12. PubMed ID: 24272480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC.
    Tao X; Wang L; Hui Z; Liu L; Ye F; Song Y; Tang Y; Men Y; Lambrou T; Su Z; Xu X; Ouyang H; Wu N
    Sci Rep; 2016 Oct; 6():35569. PubMed ID: 27762331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
    Shang J; Ling X; Zhang L; Tang Y; Xiao Z; Cheng Y; Guo B; Gong J; Huang L; Xu H
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1945-53. PubMed ID: 27236466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cone-beam computed tomography for lung cancer - validation with CT and monitoring tumour response during chemo-radiation therapy.
    Michienzi A; Kron T; Callahan J; Plumridge N; Ball D; Everitt S
    J Med Imaging Radiat Oncol; 2017 Apr; 61(2):263-270. PubMed ID: 27804280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
    Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid
    Yang DM; Palma D; Louie A; Malthaner R; Fortin D; Rodrigues G; Yaremko B; Laba J; Gaede S; Warner A; Inculet R; Lee TY
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on CT perfusion parameters of different types of lung cancer before and after chemoradiotherapy.
    Zhao L; Guan W; Han Y; Zhao Y
    J Biol Regul Homeost Agents; 2014; 28(4):675-81. PubMed ID: 25620177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.